Prognostic relevance of ARFI elastography in comparison to liver histology and the FIB-4 score

Abstract

Purpose Liver histology has prognostic relevance and is used in surveillance and therapeutic strategies. This longitudinal study was designed to evaluate the prognostic relevance of ARFI elastography in comparison to liver histology and to the FIB-4 score in a 5-year observation interval.

Materials and Methods Based on the hospital database, patients with an elastography examination of the liver between 2010–2012, a liver biopsy, and a follow-up of 5 years were included in the study. The AUROCs of the events liver-related death, HCC, and liver decompensation/variceal bleeding were calculated for ARFI elastography, liver histology, and FIB-4 and compared using the DeLong test.

Results In the final analysis 113 patients were included with 30 (26.5 %) patients having high-grade fibrosis and 19 (16.8 %) having liver cirrhosis in histology. The AUROC for liver-related death in the 5-year interval (9.7 %, n=11) was 0.80 [0.68–0.92] for ARFI elastography, 0.79 [0.66–0.92] for liver histology, and 0.66 [0.53–0.79] for FIB-4 with a p-value of 0.83 comparing ARFI to histology and a p-value of 0.02 comparing ARFI to FIB-4. The AUROC for liver decompensation/variceal bleeding (13.3 %, n=15) was 0.86 [0.76–0.94] for ARFI, which is significantly higher than the AUROC of liver histology with 0.71 [0.56–0.86] (p=0.02) and FIB-4 with 0.67 [0.54–0.80] (p=0.003). There was no significant difference for the event HCC when comparing ARFI to histology (p=0.33) or FIB-4 (p=0.14).

Conclusion The prognostic value of ARFI elastography seems to not be inferior to liver histology regarding liver-related survival and might even outperform histology and the FIB-4 score for predicting some liver-related complications.

Zusammenfassung

Ziel Die Leberhistologie hat prognostische Relevanz und wird für die Überwachung von Therapiestrategien eingesetzt. In dieser Längsschnittstudie soll die prognostische Bedeutung der ARFI-Elastografie im Vergleich zur Leberhistologie und zum FIB-4-Score in einem 5-Jahres-Intervall untersucht werden.

Material und Methode Anhand der Krankenhaus-Datenbank wurden Patienten mit einer ARFI-Untersuchung der Leber zwischen 2010–2012, einer Leberbiopsie sowie einem Follow-up von 5 Jahren in die Studie aufgenommen. Die AUROCs der Ereignisse leberabhängiges Überleben, HCC und Leberdekompensation/Varizenblutung wurden für die ARFI-Elastografie, Leberhistologie und FIB-4 berechnet und verglichen.

Ergebnisse Es wurden 113 Patienten einbezogen, von denen 30 (26,5%) eine hochgradige Fibrose und 19 (16,8%) eine Leberzirrhose aufwiesen. Die AUROC für leberabhängiges Überleben (9,7%, n=11) betrug 0,80 [0,68–0,92] für ARFI, 0,79 [0,66–0,92] für die Histologie und 0,66 [0,53–0,79] für den FIB-4 Score mit einem p-Wert von 0,83 im Vergleich ARFI vs. Histologie und einem p-Wert von 0,02 im Vergleich ARFI vs. FIB-4. Die AUROC für Leberdekompensation/Varizenblutung (13,3%, n=15) war mit 0,86 [0,76–0,94] für ARFI signifikant höher als die der Histologie mit 0,71 [0,56–0,86] (p=0,02) und FIB-4 mit 0,67 [0,54–0,80] (p=0,003). Für das Ereignis HCC gab es keinen Unterschied zwischen ARFI und Histologie (p=0,33) oder FIB-4 (p=0,14).

Schlussfolgerung Der prognostische Wert der ARFI-Elastografie scheint der Leberhistologie in Bezug auf das leberabhängige Überleben nicht unterlegen zu sein und könnte die Histologie und den FIB-4-Score bei der Vorhersage einiger leberbezogener Komplikationen übertreffen.

Keywords

ARFI elastography - liver fibrosis - liver cirrhosis - FIB-4 Score - liver histology

Publication History

Received: 26 May 2023

Accepted after revision: 12 September 2023

Article published online:
03 January 2024

• References

• 1 Rockey DC, Caldwell SH, Goodman ZD. et al. Liver biopsy. Hepatology 2009; 49: 1017-1044
• 2 Strobel D, Bernatik T, Blank W. et al. Incidence of Bleeding in 8172 Percutaneous Ultrasound-Guided Intraabdominal Diagnostic and Therapeutic Interventions – Results of the Prospective Multicenter DEGUM Interventional Ultrasound Study (PIUS Study). Ultraschall in Med 2015; 36: 122-131
• 3 Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-1457
• 4 Castera L, Pinzani M. Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango?. Gut 2010; 59: 861-866
• 5 Davison BA, Harrison SA, Cotter G. et al. Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials. J Hepatol 2020; 73: 1322-1332
• 6 Bedossa P, Carrat F. Liver biopsy: the best, not the gold standard. J Hepatol 2009; 50: 1-3
• 7 Dietrich CF, Bamber J, Berzigotti A. et al. EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography , Update 2017 (Long Version). Ultraschall in Med 2017; 38: 16-47
• 8 Mehta SH, Lau B, Afdhal NH. et al. Exceeding the limits of liver histology markers. J Hepatol 2009; 50: 36-41
• 9 de Lédinghen V, Vergniol J, Bartheet C. et al. Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus. Aliment Pharmacol Ther 2013; 37: 979-988
• 10 Vergniol J, Foucher J, Terrebonne E. et al. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 2011; 140: 1970-1979
• 11 Friedrich-Rust M, Poynard T, Castera L. Critical comparison of elastography methods to assess chronic liver disease. Nat Rev Gastroenterol Hepatol 2016; 13: 402-411
• 12 Sterling RK, Lissen E, Clumeck N. et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006; 43: 1317-1325
• 13 Castera L, Friedrich-Rust M, Loomba R. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology 2019; 156: 1264-1281
• 14 Berenguer J, Zamora FX, Aldámiz-Echevarría T. et al. Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus. Clin Infect Dis 2015; 60: 950-958
• 15 European Association for the Study of the Liver. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update. J Hepatol 2021; 75: 659-689
• 16 Nierhoff J, Chávez Ortiz AA, Herrmann E. et al. The efficiency of acoustic radiation force impulse imaging for the staging of liver fibrosis: a meta-analysis. Eur Radiol 2013; 23: 3040-3053
• 17 Pfeifer L, Zopf S, Siebler J. et al. Prospective evaluation of acoustic radiation force impulse (ARFI) elastography and high-frequency B-mode ultrasound in compensated patients for the diagnosis of liver fibrosis/cirrhosis in comparison to mini-laparoscopic biopsy. Ultraschall in Med 2015; 36: 581-589
• 18 Ishak K, Baptista A, Bianchi L. et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699
• 19 DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-845
• 20 R Core Team, R Foundation for Statistical Computing. A language and environment for statistical computing. 2020 Accessed May 14, 2023 at: https://www.r-project.org
• 21 Rasmussen DN, Thiele M, Johansenn S. et al. Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease. J Hepatol 2021; 75: 1017-1025
• 22 Choo SP, Tan WL, Goh BKP. et al. Comparison of Hepatocellular Carcinoma in Eastern versus Western Populations. Cancer 2016; 122: 3413-3579
• 23 Pfeifer L, Adler W, Zopf S. et al. Acoustic radiation force impulse elastography: Comparison and combination with other noninvasive tests for the diagnosis of compensated liver cirrhosis. Eur J Gastroenterol Hepatol 2017; 29: 524-530
• 24 Hernandez Sampere L, Vermehren J, Muecke VT. et al. Point Shear-Wave Elastography Using Acoustic Radiation Force Impulse Imaging for the Prediction of Liver-Related Events in Patients With Chronic Viral Hepatitis. Hepatol Commun 2021; 5: 112-121